FDA Clears Instantaneous Mapping System to Find the 'Source' of Cardiac Arrhythmias
CathEffects(TM) Announces FDA Clearance to Market the Desai VectorCath(TM)
SACRAMENTO, Calif., Feb. 5 /PRNewswire/ -- CathEffects(TM), LLC today announced it has received FDA clearance to market the Desai VectorCath(TM) Mapping System. The Desai VectorCath(TM) Mapping System is a cardiac electrophysiology mapping system for use with the previously FDA cleared five-electrode two-plane Desai VectorCath(TM) Mapping Catheter. This system improves procedural speed and accuracy with unprecedented ease of use. The Desai VectorCath(TM) Mapping System's proprietary software and hardware provides instantaneous directionality with distance estimate toward the endocardial site of arrhythmia breakthrough. "The Desai VectorCath(TM) Mapping System offers physicians and hospitals an economic system that reduces mapping time and improves accuracy," said Shawn Fojtik, CathEffects(TM) Chief Operating Officer. "Other mapping systems are expensive, involve significant procedure set-up time, and tend to be used only on select difficult cases. The Desai VectorCath(TM) Mapping System is inexpensive when compared to other systems, requires almost no procedure set-up time, and delivers instantaneous mapping data." Mr. Fojtik added, "During a procedure, the Desai VectorCath(TM) Mapping System can display a local isochronal activation map of the heart underneath the footprint of the catheter in less than one second. The system's map shows the physician which direction and approximately how far to move the catheter to find the source of arrhythmia." The company said that customer reaction to the Desai VectorCath(TM) Mapping Catheter and Mapping System has exceeded expectation. Electrophysiology ("EP") is a subspecialty of cardiology that examines the electrical activity of the heart with catheters placed inside the heart's chambers. During an EP procedure, the electrophysiologist can map the heart's atria and/or ventricles and identify the focus of abnormal heart rhythm. The Desai VectorCath(TM) Mapping Catheter and Mapping System were invented by Jawahar M. Desai, M.D., F.A.C.C., of Roseville, California and is licensed to CathEffects(TM) with 15 other patents. CathEffects(TM) designs, develops, and manufactures electrophysiology mapping catheters, mapping systems, and ablation catheters. CathEffects(TM), LLC is headquartered at 1100 Melody Lane, Roseville, California 95678 916-677-1790 with additional offices in Temecula, CA, Santa Clara, CA, and Park City, UT. For more information see www.catheffects.com. MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X24787745
SOURCE CathEffects, LLC
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.